Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts

Blood, Vol. 107, Issue 8, 3145-3152, April 15, 2006
This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

Arf6 plays an early role in platelet activation by collagen and convulxin
Blood Choi et al. 107: 3145

Supplemental materials for: Choi et al

Files in this Data Supplement:

  • Figure S1 (JPG, 59.5 KB) -

    (A) Resting or collagen (10 µg/mL)-stimulated platelets were lysed in 2× Rafts-Lysis buffer (50 mM MES (pH 6.5), 150 mM NaCl, 1% Triton X-100, 2× protease inhibitor cocktail), mixed with 80% sucrose solution, and layered into 15 mL ultracentrifuge tubes (Beckman Coulter, Fullerton, CA), with 30% and 5% sucrose layers added on top. Samples were centrifuged at 200,000 × g for 18 hrs, nine fractions (1 mL each) were collected, and proteins were concentrated using trichloroacetic acid (TCA) precipitation, followed by boiling with 2× SDS sample buffer. Equal amounts (15% of total lysates) were analyzed by western blot using anti-Arf6, anti-Srcp60, and anti-SNAP23. Pellet represents Triton X-100-insoluble cytoskeleton pellet and input represents 5% of total lysate. (B) Resting platelets were allowed to bind to collagen-coated coverslip, fixed, and stained with anti-Arf6 in the presence of 0.2% saponin and 10% FBS, followed by incubation with FITC-conjugated anti-rabbit antibody (Arf6) and TRITC-conjugated phalloidin (F-actin).

  • Figure S2 (JPG, 59.9 KB) -

    (A) Washed platelets (4 × 108/mL) were incubated with DMSO or myr-Arf6 peptide (25 µM) for 2 min with stirring at 37°C, followed by the stimulation with 0.1 µg/mL convulxin for the indicated times. The platelet suspensions were lysed and the supernatants were used to analyze Arf6-GTP. Five percent of the supernatants were analyzed by western blot as input controls. (B) Washed platelets were lysed and the supernatants were used to probe for Arf6-GTP using GST alone, GST-VHS, and GST-VHS-GAT. Western blot were performed using anti-Arf6 antibody. (C) Washed platelets were stimulated with indicated concentrations of convulxin. After incubation for the indicated times, platelets were lysed and the supernatant were analyzed for Arf6-GTP. (D) Washed platelets were incubated with DMSO (Resting and collagen) or myr-Arf6 peptide (25 µM) for 2 min with stirring at 37°C, followed by the stimulation with 10 µg/mL collagen. After incubation for the indicated times, platelets were lysed and the supernatant were analyzed for Arf1/3-GTP using GST-GGA3. (E) Washed platelets were incubated with 1% methanol (MeOH) or BFA (10 µg/mL) for 5 min with stirring at 37°C, followed by stimulation with 10 µg/mL collagen. Aggregation was monitored using aggregometer.




This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020